Clinical Trial Update: Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 study in ICU patients is investigating contrast agent–associated nephrotoxicity. The trial status is UNKNOWN and the sponsor is the University …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Snippet

Sponsor: University of Thessaly | Conditions: Contrast Induced Nephropathy | EARLY_Phase 1 | Status: UNKNOWN